25021-783 : Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution


NDC25021-783
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Palonosetron Hydrochloride
Dosage Form: Intravenous Injection, Solution
Application #: ANDA204289
Rev. Date: 


NDC Package Codes:

  • 25021-783-05: 1 VIAL IN 1 CARTON (25021‑783‑05) > 5 ML IN 1 VIAL

Active Ingredients:

  • Palonosetron Hydrochloride

Dosage Strength:

  • .05 mg/mL

Pharmaceutical Classes:

  • Serotonin 3 Receptor Antagonists [MoA]
  • Serotonin-3 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 25021-788 Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 0143-9513 Palonosetron Hydrochloride .25 mg/2ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0409-2504 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Hospira, Inc.
  • 0703-4094 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0781-3312 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3415 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Sandoz Inc
  • 16729-365 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Accord Healthcare, Inc.
  • 55150-186 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 67457-317 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 69097-439 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Cipla USA Inc.
  • 69097-927 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Cipla USA Inc.
  • 69543-371 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Virtus Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-783 QR Code

< Prev: 25021-782Next: 25021-784 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 June 2018.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA